ACM
HCAT icon

Advent Capital Management’s Health Catalyst HCAT Stock Holding History

Advent Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-65,000
Closed -$529K – 228
2024
Q3 		$529K Buy
+65,000
New +$470K 0.01% 197

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Advent Capital Management's HCAT Position: Q4 2024 in Review

Advent Capital Management sold out of Health Catalyst (HCAT) in Q4 2024, closing a stake of 65,000 shares — an estimated $529K sold.

Advent Capital Management first reported a position in HCAT in Q3 2024 and held it in 1 quarter. The position peaked at $529K in Q3 2024. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2024.

  • Advent Capital Management reported no remaining Health Catalyst position as of Q4 2024 after selling out during the quarter.
  • Advent Capital Management sold 65,000 Health Catalyst shares in Q4 2024, an estimated $529K.
  • Advent Capital Management first reported a position in Health Catalyst in Q3 2024 and held it in 1 quarter.
  • Advent Capital Management's Health Catalyst position peaked at $529K in Q3 2024.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2024.

Based on Advent Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.